title: Consideration of an association between performance status and ramucirumab efficacy.
authors.affiliation: Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
authors.forename: H H
authors.initials: HH
authors.lastname: Yoon
authors.affiliation: GI Cancer Research Program, Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA.
authors.forename: J C
authors.initials: JC
authors.lastname: Bendell
authors.affiliation: Division of Hematology Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Wainberg
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018572:Disease-Free Survival; D006801:Humans; D000096662:Ramucirumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000096662:Ramucirumab